Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
RtS5HL9ueUshmzPD
